Clinical features and management strategies of ectopic kidney: a 25-year single-center retrospective analysis

异位肾的临床特征和治疗策略:一项为期25年的单中心回顾性分析

阅读:1

Abstract

BACKGROUND: Ectopic kidney is a rare congenital anomaly characterized by abnormal renal ascent and frequent structural variants that predispose to urologic complications. This study aimed to investigate the clinical features, anatomical variations, and treatment strategies in patients with ectopic kidneys to inform individualized management. METHODS: This single-center retrospective cohort included 95 patients (100 ectopic kidneys). Clinical data, including imaging findings, complications and treatment modalities, were collected. Anatomical characteristics, such as the location, rotation, and vascular variations of the ectopic kidneys, were evaluated through imaging. Surgical interventions were performed for urolithiasis, hydronephrosis and renal tumor patients. RESULTS: The median diagnostic age was 37.0 years [interquartile range (IQR), 22.5-57.0 years], with 51/95 (53.7%) patients male and 44/95 (46.3%) female. Among the 100 ectopic kidneys, 63 (63.0%) were located in the pelvis, 24 (24.0 %) in the iliac fossa and 13 (13.0%) in the abdomen. Malrotation was observed in 55 of the 60 ectopic kidneys evaluated (91.7%). Vascular variations, including multiple vessels and anomalous origins, were common. Sixty patients (63.2%) were asymptomatic, whereas 14 (14.7%) reported abdominal or lumbar pain and 6 (6.3%) presented with hematuria. Urolithiasis affected 12 kidneys (12.0%), hydronephrosis occurred in 15 (15.0%), and renal tumors were present in 6 cases (6.0%). Twenty-six patients underwent surgery: 9 (34.6%) received transurethral endoscopic procedures, 8 (30.8%) underwent open surgery and 9 (34.6%) had laparoscopic surgery. CONCLUSIONS: Ectopic kidneys are frequently associated with structural abnormalities, such as malrotation and vascular variations, and are predisposed to complications, including urolithiasis and hydronephrosis. Early diagnosis, individualized treatment, and lifelong follow-up are essential for improving patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。